China-based Autobio Diagnostics Co., Ltd (SHA: 603658) has announced a strategic partnership with Guorun Medical Supply Chain Services (Shanghai) Co., Ltd, along with 11 shareholding companies. This collaboration aims to enhance the procurement and distribution of in vitro diagnostic (IVD) products and services, ensuring a robust supply chain and fostering mutual growth.
Deepening Strategic Partnership
The partnership between Autobio Diagnostics and Guorun Medical Supply Chain Services is set to deepen, with a focus on strengthening cooperation in the IVD sector. The two firms are committed to achieving smooth supply chain circulation, which is crucial for the timely delivery of diagnostic products and services.
Enhancing Cooperation and Resource Sharing
Through this partnership, Autobio Diagnostics and Guorun Medical Supply Chain Services will strengthen communication and exchange, sharing market information and resources. This collaboration will provide strong support for each company’s development, leveraging the combined strengths and expertise of both entities.
Supporting Development and Growth
The joint efforts of Autobio Diagnostics and Guorun Medical Supply Chain Services will not only enhance their respective operations but also contribute to the overall growth of the IVD market in China. By working together, the two firms aim to provide more efficient and effective diagnostic solutions, meeting the needs of healthcare providers and patients.- Flcube.com
